NCT03998696View on ClinicalTrials.gov

An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Cisplatin 40 mg/m2

Cisplatin 40 mg/m2, weekly, concurrent with Radiotherapy

DRUG

Cisplatin 100 mg/m2

Cisplatin 100 mg/m2, three weekly, concurrent with Radiotherapy

Trial Locations (1)

1000

Bangabandhu Sheikh Mujib Medical University, Dhaka

All Listed Sponsors
lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT03998696 - An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer. | Biotech Hunter | Biotech Hunter